SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051

FDA Device Recall #Z-0162-2022 — Class II — September 23, 2021

Recall Summary

Recall Number Z-0162-2022
Classification Class II — Moderate risk
Date Initiated September 23, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm DiaSorin Molecular LLC
Location Cypress, CA
Product Type Devices
Quantity 1690 kits

Product Description

SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051

Reason for Recall

Due to unapproved raw materials used in the manufacturing of Covid-19 control pack, their is the potential for delayed amplification signals.

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the states of AL, AZ, CA, CO, DE, FL, GA, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, NC, ND, NE, NJ, NV, NY, OH, OK, PA, SD, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Italy.

Lot / Code Information

Lot #/Expiration Date: 12175N/11.30.2021, 12722N/01.31.2022, X12122N/01.31.2022, X12724N/08.31.2022

Other Recalls from DiaSorin Molecular LLC

Recall # Classification Product Date
Z-2153-2023 Class II Simplexa Direct Amplification Disc Kit, Rx Only... Jun 14, 2023
Z-1209-2023 Class II Simplexa COVID-19 Direct, REF: MOL4150; includi... Jan 30, 2023
Z-1210-2023 Class II Simplexa Flu A/B & RSV Direct Gen II, REF: MOL2... Jan 30, 2023
Z-0457-2022 Class II Simplexa Direct Amplification Disc Kit, Product... Nov 19, 2021
Z-2549-2020 Class II MOL3655 Simplexa VZV Swab Direct - Product Usag... May 12, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.